Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 10;6(2):dlae057.
doi: 10.1093/jacamr/dlae057. eCollection 2024 Apr.

Heteroresistance to piperacillin/tazobactam in Klebsiella pneumoniae is mediated by increased copy number of multiple β-lactamase genes

Ahmed Babiker  1 , Sarah Lohsen  1 , Julia Van Riel  1 , Karin Hjort  2 , David S Weiss  1 , Dan I Andersson  2 , Sarah Satola  1
Affiliations

Heteroresistance to piperacillin/tazobactam in Klebsiella pneumoniae is mediated by increased copy number of multiple β-lactamase genes

Ahmed Babiker et al. JAC Antimicrob Resist. .

Abstract

Background: Piperacillin/tazobactam is a β-lactam/β-lactamase inhibitor combination with a broad spectrum of activity that is often used as empirical and/or targeted therapy among hospitalized patients. Heteroresistance (HR) is a form of antibiotic resistance in which a minority population of resistant cells coexists with a majority susceptible population that has been found to be a cause of antibiotic treatment failure in murine models.

Objectives: To determine the prevalence of HR and mechanisms of HR to piperacillin/tazobactam among Klebsiella pneumoniae bloodstream infection (BSI) isolates.

Materials: From July 2018 to June 2021, K. pneumoniae piperacillin/tazobactam-susceptible BSI isolates were collected from two tertiary hospitals in Atlanta, GA, USA. Only first isolates from each patient per calendar year were included. Population analysis profiling (PAP) and WGS were performed to identify HR and its mechanisms.

Results: Among 423 K. pneumoniae BSI isolates collected during the study period, 6% (25/423) were found to be HR with a subpopulation surviving above the breakpoint. WGS of HR isolates grown in the presence of piperacillin/tazobactam at concentrations 8-fold that of the MIC revealed copy number changes of plasmid-located β-lactamase genes blaCTX-M-15, blaSHV33, blaOXA-1 and blaTEM-1 by tandem gene amplification or plasmid copy number increase.

Conclusions: Prevalence of HR to piperacillin/tazobactam among bloodstream isolates was substantial. The HR phenotype appears to be caused by tandem amplification of β-lactamase genes found on plasmids or plasmid copy number increase. This raises the possibility of dissemination of HR through horizontal gene transfer and requires further study.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Prevalence of HR by MIC. MIC determined by testing on the VITEK 2 (bioMérieux) as part of routine clinical care.
See this image and copyright information in PMC

References

    1. Strich JR, Lawandi A, Warner S et al. Association between piperacillin/tazobactam MIC and survival among hospitalized patients with Enterobacterales infections: retrospective cohort analysis of electronic health records from 161 US hospitals. JAC Antimicrob Resist 2023; 5: dlad041. 10.1093/jacamr/dlad041 - DOI - PMC - PubMed
    1. Harris PNA, Tambyah PA, Lye DC et al. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA 2018; 320: 984–94. 10.1001/jama.2018.12163 - DOI - PMC - PubMed
    1. Andersson DI, Nicoloff H, Hjort K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat Rev Microbiol 2019; 17: 479–96. 10.1038/s41579-019-0218-1 - DOI - PubMed
    1. CLSI . Performance Standards for Antimicrobial Susceptibility Testing—Thirty-First Edition: M100. 2021.
    1. Abbott C, Satola SW, Weiss DS. Heteroresistance to cefepime-taniborbactam in metallo-β-lactamase-encoding Enterobacterales. Lancet Infect Dis 2023; 23: e277–8. 10.1016/S1473-3099(23)00426-7 - DOI - PubMed

LinkOut - more resources